NCT05713617 (PODER) is a NA clinical trial of PODER Familiar in Health-Related Behavior, sponsored by University of Texas at Austin.

Who is sponsoring NCT05713617?

NCT05713617 is sponsored by University of Texas at Austin.

What drugs are being tested in NCT05713617?

Interventions in NCT05713617: PODER Familiar.

What condition does NCT05713617 study?

NCT05713617 studies Health-Related Behavior, Quality of Life, Psychological Distress, Diet, Healthy, Physical Inactivity.

Is NCT05713617 still recruiting?

NCT05713617 is currently recruiting now. Last updated 26 July 2024.

Last reviewed 2024-07-26 · How we verify

NCT05713617: PODER

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

PODER Familiar: Health Promotion for Latino Families of Children With IDD

Recruiting now NA Last updated 26 July 2024

What this trial tests

NA trial testing PODER Familiar in Health-Related Behavior in 90 participants. Currently enrolling.

Timeline

17 January 2023

Primary endpoint
30 September 2024

30 September 2024

Quick facts

Lead sponsor	University of Texas at Austin
Phase	NA
Status	Recruiting now
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	prevention
Enrollment	90
Start date	17 January 2023
Primary completion	30 September 2024
Estimated completion	30 September 2024
Sites	2 locations across United States

Drugs / interventions tested

PODER Familiar

Conditions studied

Health-Related Behavior — all drugs for Health-Related Behavior →
Quality of Life — all drugs for Quality of Life →
Psychological Distress — all drugs for Psychological Distress →
Diet, Healthy — all drugs for Diet, Healthy →

Sponsor

University of Texas at Austin

Who can join

Adults 6 to 100, any sex, with Health-Related Behavior or Quality of Life. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this clinical trial is to test a culturally tailored health promotion intervention for children with IDD and their families. First investigators will conduct a single group design pilot study of a health promotion intervention, followed by second, a small-scale randomized control trial (RCT). of the intervention with Latino parents of children with intellectual and developmental disabilities (IDD) in the Chicago, Illinois and Austin, Texas areas. The following research questions will be addressed: Question 1: What is the appropriate content, dosage, and delivery method of the intervention? Question 2: What is the feasibility and acceptability of the intervention? Question 3: Do participants improve between pre and post-test on outcome measures both in the one group design and compared to the control group in the RCT? Parents will receive 10 weekly remote sessions on health promotion content delivered by parent mentors called promotoras. Parents and children will attend 3 multi-family group workshops in-person that will provide demonstrations and interactive activities.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

PODER Familiar: A Culturally Tailored Health Intervention for Latino Families of Children With Intellectual and Developmental Disabilities.
Yu AP, Suarez-Balcazar Y, Errisuriz VL, Parra-Medina D, et al · · 2025 · cited 3× · PMID 40186534 · DOI 10.1111/jar.70048

Verify or expand the search:

Other recruiting trials for Health-Related Behavior

Currently open trials in the same condition.

NCT07176195 — The Impact of Eating Habits on the Health of Employees in the Defense Sector · active not recruiting
NCT06731452 — Exploring Neurophysiological Markers of Brain Health · NA · recruiting
NCT07310017 — Yoga With and Without VR for Core, Balance, and Stress in University Students · NA · recruiting
NCT06497816 — Health Literacy, Physical and Cognitive Function, Health-related Behaviors, and Quality of Life in COPD · recruiting
NCT06404632 — A Group Intervention for Promoting Health-related Habits (LEV-G) · NA · recruiting

Other University of Texas at Austin trials

Trials by the same sponsor.

NCT07319234 — Development of MENU Protocol · NA · not yet recruiting
NCT07480109 — Increased Dietary Protein Intake During GLP-1 Medication Use (in Middle-aged Women With Overweight/Obesity) · NA · not yet recruiting
NCT07069413 — Sibwatch: Optimizing Intervention Options for Infants and Toddler Siblings of Autistic Children · NA · not yet recruiting
NCT07370311 — A Culturally Adapted Decision Aid Intervention to Support Chinese American Dementia Caregivers in Feeding-Related Decisi · NA · not yet recruiting
NCT07441122 — Enhancing Attention in Elderly Using a Brain-Computer-Interface · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05713617 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Texas at Austin
Last refreshed: 26 July 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05713617.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing